PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer
NCT04983459 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 205
Last updated 2021-07-30
Summary
The aim of this study is to evaluate PSMA-PET for the detection of occult biological recurrence in patients with prostatic cancer referred to the Brest University Hospital.
Conditions
- Prostatic Neoplasms
- Recurrence
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- France
Study Locations
More Related Trials
-
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
NCT04742361 ·Status: COMPLETED ·Phase: PHASE3
-
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma
NCT01304485 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Medical Imaging Quantization in Prostate Cancer
NCT03376360 ·Status: COMPLETED
-
18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.
NCT05048537 ·Status: UNKNOWN ·Phase: NA
-
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
NCT01777061 ·Status: NO_LONGER_AVAILABLE
-
Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients
NCT05819606 ·Status: COMPLETED
-
PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and Reproducibility
NCT03486886 ·Status: COMPLETED ·Phase: NA
-
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
NCT07234981 ·Status: RECRUITING ·Phase: PHASE2
-
PSMA PET Imaging of Recurrent Prostate Cancer
NCT03204123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PSMA PET for Surveillance After Focal Therapy
NCT07115914 ·Status: RECRUITING ·Phase: NA
-
PSMA-PET/CT for Prostate Cancer
NCT03558711 ·Status: COMPLETED ·Phase: PHASE1
-
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06756334 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NCT03149861 ·Status: COMPLETED ·Phase: NA
-
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
NCT03768349 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI
NCT04063800 ·Status: COMPLETED
-
Study of Diagnostic Performance of [18F]CTT1057 in BCR
NCT04838613 ·Status: COMPLETED ·Phase: PHASE3
-
The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer
NCT05958004 ·Status: COMPLETED
-
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
NCT06122584 ·Status: RECRUITING ·Phase: PHASE3
-
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques
NCT02935816 ·Status: UNKNOWN
-
PSMA-PET/CT Registry
NCT05709535 ·Status: TERMINATED
-
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
NCT02673151 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage
NCT04116086 ·Status: UNKNOWN ·Phase: NA
-
PSMA PET/CT for Prostate Cancer
NCT03573011 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of Lymph Node Invasion for Prostate Adenocarcinoma
NCT04909957 ·Status: UNKNOWN
-
Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features
NCT06604377 ·Status: COMPLETED